| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jun 6, 2025 | Jun 9, 2025 | Metagenomi, Inc. | Chief Medical Officer | Sell | 47.5 | -5,239 | -4.58% | ✗ | $9.2K |
| Feb 10, 2021 | Feb 12, 2021 | Protagonist Therapeutics, Inc | Director | Sell | 53.8 | - | 0.00% | ✓ | $212.6K |